New hope for kids tied to blood transfusions: trial aims to cut lifeline need

NCT ID NCT05144256

Summary

This study is testing whether a drug called mitapivat can help children with pyruvate kinase deficiency (PK deficiency), a rare genetic disorder that destroys red blood cells, rely less on regular blood transfusions. About 49 children, aged 1 to 18, who currently need frequent transfusions will receive either the study drug or a placebo for 32 weeks to see if it reduces their transfusion needs. The main goal is to see if the drug can safely cut the total volume of blood they need by at least one-third.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC PYRUVATE KINASE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aarhus University Hospital

    Aarhus, Central Jutland, 8200, Denmark

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

  • CHUV University Hospital of Lausanne

    Lausanne, Canton of Bern, Switzerland

  • Charite - UB - CVK - Medizinische Klinik

    Berlin, 13353, Germany

  • Children's Healthcare of Atlanta - Emory

    Atlanta, Georgia, 30322, United States

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Comprehensive Hemophilia Care Clinic at CHEO (Children's Hospital Eastern Ontario)

    Ottawa, Ontario, K1H 5B2, Canada

  • Cure 4 the Kids Foundation, A Division of Roseman University of Health Sciences

    Las Vegas, Nevada, 89135, United States

  • Ege University Faculty of Medicine

    Izmir, Adana, Turkey (Türkiye)

  • Fakultní Nemocnice Olomouc

    Olomouc, 779 00, Czechia

  • Hacettepe University

    Ankara, Turkey (Türkiye)

  • Hospital Clinico Universitario Virgen de la Arrixaca

    Madrid, 30120, Spain

  • Hospital Universitario Vall d'Hebron

    Barcelona, 08035, Spain

  • King's College Hospital NHS

    London, SE5 9RS, United Kingdom

  • Phoenix Children's Hospital

    Phoenix, Arizona, 85016, United States

  • Rigshospitalet

    Copenhagen, 2100, Denmark

  • Stanford Medicine

    Palo Alto, California, 94304, United States

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

  • UT Southwestern Medical Center

    Dallas, Texas, 75390, United States

  • Universitair Medisch Centrum Utrecht

    Utrecht, 3584 CX, Netherlands

  • Weill Cornell Medical College

    New York, New York, 10065, United States

  • İstanbul Üniversitesi Tıp Fakültesi [Istanbul University Faculty of Medicine] Çocuk Sağlığı Enstitüsü [Institute of Child Health]

    Istanbul, 34093, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.